The clinical utility of molecular stratification in colorectal cancer
Microbiome from stool, tumor and adjacent normal tissue swabs in colorectal cancer: data from MMCI patients
Right-sided primary tumor location confers a worse prognosis regardless KRAS status in patiens with metastatic colorectal cancer treated with 1st-line anti-VEGF plus chemotherapy
Elementary circulating immune cells predict clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients in the context of KRAS mutation and primary tumor sidedness
networking
Dr. Philip Dunne, Dr. Beatrix Bencsiková, Dr. Radka Obermannová, Dr. Eva Budinská, Dr. Vlad Popovici, Dr. Rudolf Nenutil, Dr. Marek Svoboda, Dr. Lenka Zdrazilova Dubska
Dr. Philip Dunne
Queen's University Belfast
Dr. Eva Budinská
Masarykův onkologický ústav, RECETOX
Dr. Radka Obermannová
Masarykův onkologický ústav
Dr. Lenka Zdražilová Dubská
Masarykův onkologický ústav